|
Reducing trial cost and time
Increasing significance of efficacy detection
Our conduct of sample
biomarker measurements has demonstrated superior
trial powering for
efficacy detection and lower patient number requirements
(Figure
1); confirmed by
independent study (1)
Aeirtec’s 20 years experience in clinical trial
conduct, analysis and clinical trial
design consultancy provides you with
confidence in your Phase
I to IV clinical
or preclinicalstudy sample data and
reporting
Our integrated
immune-inflammatory pharmacology laboratories will also
conduct parallel flow cytometry of your blood
samples for cell activation status
and intracellular cytokine production
Benefits and Capacity of our Sample Biomarker
Measurement
To discuss your requirements email: info@aeirtec.co.uk
Benefits and Quality of our Data
Aeirtec’s studies have
demonstrated the direct beneficial effect of the number
of sample replicates
that Aeirtec uses on study power for efficacy detection and
the number of subjects required; directly impacting on
the success, time and cost
of your study (figure 1)
Independent studies have
demonstrated the problems other testing centres
produce when measuring samples
in duplicate or even singlet in which
outliers cannot be detected (Djoba Siawaya
JF, et al. (2008))
To derive optimal
value from your samples, it is essential that Aeirtec measures
your samples in a minimum
of three replicates (figure 1)
Capacity and Advice
| 
